Bio-Techne Corporation (FRA:TE1)

Germany flag Germany · Delayed Price · Currency is EUR
54.50
0.00 (0.00%)
Last updated: Dec 4, 2025, 8:00 AM CET
-23.78%
Market Cap 8.26B
Revenue (ttm) 1.04B
Net Income (ttm) 66.44M
Shares Out n/a
EPS (ttm) 0.41
PE Ratio 124.35
Forward PE 30.43
Dividend 0.29 (0.52%)
Ex-Dividend Date Nov 17, 2025
Volume n/a
Average Volume n/a
Open 54.50
Previous Close 54.50
Day's Range 54.50 - 54.50
52-Week Range 40.60 - 75.50
Beta n/a
RSI 54.27
Earnings Date Jan 30, 2026

About Bio-Techne

Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Spatial Biology. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue cultur... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 1976
Employees 3,100
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol TE1
Full Company Profile

Financial Performance

In 2025, Bio-Techne's revenue was $1.22 billion, an increase of 5.23% compared to the previous year's $1.16 billion. Earnings were $73.36 million, a decrease of -56.35%.

Financial numbers in USD Financial Statements

News

There is no news available yet.